Summary
Nitrates relieve symptoms and improve left ventricular haemodynamics during acute myocardial ischaemia. The ability to increase cardiac output appears to be greatest in those patients with the most severe left ventricular failure. In humans and in animal experiments it has been demonstrated that indices of infarct evolution are reduced by early (<6 hours) administration of nitrate. Glyceryl trinitrate reduces myocardial oxygen consumption and improves delivery of oxygen to the ischaemic subendocardium. In addition, nitrates dilate epicardial coronary vessels with improvement of collateral flow. Glyceryl trinitrate appears to have a more favourable effect on coronary collateral flow, pulmonary artery pressure, myocardial oxygen consumption and lactate production than other vasodilators. The effect of glyceryl trinitrate is dose dependent; doses larger than 100μg/min may cause a paradoxical increase in the ischaemic condition. Hypovolaemic patients or patients with right heart infarction seem especially susceptible to hypotension. Nitrate-induced hypotension occurs in 15 to 20% of all patients with acute myocardial infarction.
Administration of glyceryl trinitrate appears to offer most benefit in acute myocardial infarction complicated by significant left ventricular dysfunction. There is evidence that morbidity and mortality are reduced by early administration of nitrates; however, a properly conducted randomised double-blind trial remains to be performed.
Similar content being viewed by others
References
Armstrong PW, Walker DC, Burton JR, Parker JO. Vasodilator therapy in acute myocardial infarction: a comparison of sodium nitroprusside and nitroglycerin. Circulation 52: 1118–1122, 1975
Borer JS, Kent KM, Goldstein RE, Epstein SE. Nitroglycerin induced reduction in the incidence of spontaneous ventricular fibrillation during coronary occlusion in dogs. American Journal of Cardiology 33: 517–520, 1974
Bussmann WD, Haller M. Hinweis auf eine Abnahme der Früh-und Spätmortalität beim frischen Herzinfarkt unter Nitroglycerintherapie. Klinische Wochenschrift 61: 417–422, 1983
Bussmann WD, Löhner J, Kaltenbach M. Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction. American Journal of Cardiology 39: 91–95, 1977
Bussmann WD, Schöfer H, Kurita A, Ganz W. Nitroglycerin in acute myocardial infarction. X. Effect of small and large doses of nitroglycerin on sigma ST segment deviation —experimental and clinical results. Clinical Cardiology 2: 106–112, 1979
Bussmann WD, Passek D, Seidel W, Kaltenbach M. Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin. Circulation 63: 615–622, 1981
Bussmann WD, Neumann K, Kaltenbach M. Effects of intravenous nitroglycerin on ventricular ectopic beats in acute myocardial infarction. American Heart Journal 107: 940–944, 1984
Come P, Pitt B. Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circulation 54: 624–628, 1976
Chiariello M, Gold HK, Leinbach RC, Davis MA, Maroko PR. Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation 5: 766–773, 1976
Derrida JP, Sal R, Chiche P. Favourable effects of prolonged nitroglycerin infusion in patients with acute myocardial infarction. American Heart Journal 96: 833–834, 1978
Flaherty JT, Reid PR, Kelly DT, Taylor DR, Weisfeldt ML, et al. Intravenous nitroglycerin in acute myocardial infarction. Circulation 51: 132–139, 1975
Flaherty JT, Magee PA, Gardner TL, Potter A, MacAllister NP. Comparison of intravenous nitroglycerin and sodium nitroprusside for treatment of acute hypertension developing after coronary artery bypass surgery. Circulation 65: 1072–1077, 1982
Flaherty JT, Becker LC, Bulkley BH, Weiss JL, Gerstenblith G, et al. A randomised prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction. Circulation 68: 576–588, 1983
Gharaibeh MN, Gross GJ. Comparative relaxant effects of nitroglycerin in isolated rings from various canine vascular beds. General Pharmacology 15: 217–221, 1984
Gold HK, Leinbach RC, Sanders CA. Use of sublingual nitroglycerin in congestive failure following acute myocardial infarction. Circulation 46: 839–845, 1972
Goldstein RE, Stinson EB, Scherer JL, Seningen RP, Grehl TM, et al. Intraoperative coronary collateral function in patients with coronary occlusive disease. Circulation 49: 298–308, 1974
Gorman MW, Sparks Jr HV. Nitroglycerin causes vasodilation within ischaemic myocardium. Cardiovascular Research 14: 515–521, 1980
Grosser KD, Schuster P, Freund M, Knoch K, Sturm A. Oral ISDN for the treatment of patients with acute myocardial infarction. Zeitschrift für Kardiologie 72 (Suppl. 3): 147–151, 1983
Ihlen H. Different effects of nitroglycerin and nitroprusside on myocardial blood flow and metabolism. Scandinavian Journal of Clinical and Laboratory Investigation 44 (Suppl. 173): 75–79, 1984
Jaffe AS, Geltman EM, Tiefenbrunn AJ, Ambos HD, Strauss HD, et al. Reduction of infarct size in patients with inferior infarction with intravenous glyceryl trinitrate. British Heart Journal 49: 452–460, 1983
Jugdutt BI. Myocardial salvage by intravenous nitroglycerin in conscious dogs: loss of beneficial effect with marked nitroglycerin-induced hypotension. Circulation 68: 673–684, 1983
Jugdutt BI, Sussex BA, Warnica JW, Rossall RE. Persistent reduction in left ventricular asynergy in patients with acute myocardial infarction by intravenous infusion of nitroglycerin. Circulation 68: 1264–1273, 1983
Kent KM, Smith ER, Redwood DR, Epstein SE. Beneficial electrophysiologic effects of nitroglycerin during acute myocardial infarction. American Journal of Cardiology 33: 513–516, 1974
Knoebel SB, Rasmussen S, Noble RJ, Mihalick MJ. Nitroglycerin and premature ventricular complexes in myocardial infarction. British Heart Journal 37: 1064–1068, 1975
Korewicki J, Kraska T, Opolski G, Ostrzycki A, Palynyczko Z. Beneficial effects of intravenous nitroglycerin on haemodynamics and enzymatically estimated infarct size. European Heart Journal 5: 697–704, 1984
Lévites R, Bodenheimer MM, Helfant RH. Electrophysiologic effects of nitroglycerin during experimental coronary occlusion. Circulation 52: 1050–1055, 1975
Lis Y, Bennet D, Lambert G, Robson D. A preliminary double blinded study of intravenous nitroglycerin in acute myocardial infarction. Intensive Care Medicine 10: 179–184, 1984
Müller O, Rørvik K. Haemodynamic consequences of coronary heart disease: with observations during anginal pain and on the effect of nitro-glycerin. British Heart Journal 20: 302–310, 1958
Osuna PP, Moreno LMG, Jimenez AA, Sanchez-Castillo AS, Luengo CM, et al. Isosorbide dinitrate sublingual therapy for inferior myocardial infarction: randomised trial to assess infarct size limitation. American Journal of Cardiology 55: 330–334, 1985
Rafflenbeul W, Urthaler F, Russell RO, Lichtlen P, James TN. Dilatation of coronary artery stenoses after isosorbide dinitrate in man. British Heart Journal 43: 546–549, 1980
Sederholm M, Grøttum P, Erhardt L, Kjekshus JK. Quantitative assessment of myocardial ischaemia and necrosis by continuous vector cardiography and measurement of creatine kinase release in patients. Circulation 68: 1006–1012, 1983
Zaslavskaya RM, Pokazeeva ZT, Teiblium MM. Comprehensive assessment of the effectiveness of nitrates with prolonged action in patients with acute myocardial infarction. Cor Vasa 27(6): 397–405, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kjekshus, J. Nitrates in Acute Myocardial Infarction. Drugs 33 (Suppl 4), 140–146 (1987). https://doi.org/10.2165/00003495-198700334-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198700334-00026